Most people watch the stock market like a heartbeat monitor.
But the truth is, by the time the market "tells" you something, it's already too late.
Every major crash in the last century had early warning signals that almost nobody was watching.
That's why we created The Bellwether Signal:
A free report revealing the 7 key indicators that have predicted every major economic collapse since 1929.
Right now, all seven are flashing red simultaneously for the first time since 2007.
These aren't the signals you'll see on CNBC.
If you're wondering how to protect your retirement, the answer may not be more stocks or more bonds.
It's about moving a portion of your savings into hard, tangible assets like gold and silver that have historically outperformed during every crisis.
Get the full story, and your free copy of The Bellwether Signal, while it's still available.
Global Medical: This REIT Just Got a 30% Price Target
Written by Sam Quirke. Published 10/20/2025.
Key Points
- Global Medical REIT’s multi-year downtrend may finally be ending.
- Fresh analyst upgrades are indicating as much as a nearly 30% upside from current levels.
- A juicy 9.3% dividend yield adds to an increasingly attractive risk/reward setup.
Real Estate Investment Trusts, or REITs, are a favorite among income investors. They offer regular dividends, provide easy exposure to tangible assets, and can serve as a natural hedge against inflation. Within that universe, Global Medical REIT Inc. (NYSE: GMRE) stands out as a niche player focused on healthcare properties. Its portfolio includes medical office buildings, outpatient facilities, and specialty care centers—all backed by long-term leases and stable tenants.
Frustratingly for investors, that brick-and-mortar stability hasn't translated into share-price strength. Global Medical's stock has been in a persistent decline since December 2021, losing more than 60% of its value. Several factors contributed to the slide, and the stock hit fresh all-time lows earlier this month.
A Worldwide Gold Lockdown Is Now Underway (Ad)
Central banks around the world are hoarding gold at one of the fastest rates in history — and former Goldman Sachs VP Dr. David Eifrig says this move goes far beyond a simple bull market. In a new free presentation, he reveals why the world's financial elite are locking down gold, what it could mean for your savings, and the three steps he recommends taking immediately.
Click here to watch Dr. Eifrig's full broadcast before it's taken offlineAfter years of relentless selling, however, there are finally signs of a bottom forming. With several analysts starting to turn bullish and the technical picture improving, there are reasons to think Global Medical's long-awaited recovery may be taking shape. Let's take a closer look.
A Brutal Downtrend, But a Clear Floor Emerging
Much of the stock's decline can be attributed to higher interest rates and investor skepticism toward debt-heavy real estate names. The situation was compounded when management trimmed the dividend by 29% earlier this year, which weakened investor confidence just as the shares were consolidating.
Despite sliding since that cut, the stock may have found a floor. The $30 level has emerged as a key line of support: it's where selling pressure eased last May, and buyers have stepped in again. Over the past week, shares bounced sharply off the $30 mark, suggesting that larger investors may be quietly accumulating positions.
Momentum indicators are beginning to favor the bulls. The RSI has rebounded from deeply oversold territory, and the stock's MACD is nearing a bullish crossover. After nearly four years of downward pressure, Global Medical's chart is showing early signs of stabilizing—making this an interesting entry point for sidelined investors.
Analysts Are Turning Bullish Again
Wall Street sentiment appears to be shifting. Earlier this week, Citizens JMP upgraded its rating on Global Medical from Market Perform to Outperform and set a new price target of $40. From Wednesday's close, that implies nearly 30% upside.
That call follows Zacks Research's upgrade to Strong Buy last month, reflecting growing optimism among analysts that much of the downside has been priced in. Improvements to the company's balance sheet and a more supportive macro backdrop are cited as reasons for the more positive outlook.
The broader environment for REITs is also improving. Expectations of future interest-rate cuts would relieve pressure on yield-sensitive stocks like Global Medical, and the company's recently announced $50 million share repurchase program provides an additional layer of support.
The new CEO's focus on deleveraging further signals management's intent to turn the page on a difficult period for shareholders.
For investors considering entry around the $30 mark, the company's 9.31% dividend yield is attractive—it offers a meaningful income stream even if the recovery takes time.
Risks Remain, But The Setup Is Compelling
That said, risks remain. Global Medical is still highly sensitive to interest-rate moves, and the timing of any Fed rate cuts is uncertain. The company also faces lingering skepticism from investors who have watched the stock underperform while the broader market made gains earlier this year.
Even so, the risk/reward profile looks favorable at current levels. After a roughly 60% peak-to-trough decline, much of the negative news appears reflected in the price, and the recent analyst upgrades suggest sentiment is shifting.
If shares can hold above $30 through the rest of October, it would strengthen the case that a durable base has formed. From there, technicals and analyst targets point to room for a meaningful rebound into year-end.
This message is a paid advertisement provided by American Alternative, a third-party advertiser of MarketBeat. Why did I get this message?.
If you need help with your account, please don't hesitate to contact MarketBeat's U.S. based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2025 MarketBeat Media, LLC. All rights protected.
345 N Reid Place #620, Sioux Falls, SD 57103-7078. USA..
Post a Comment
Post a Comment